Literature DB >> 18988082

Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog.

R Smith1, R D O Jones, P G Ballard, H H Griffiths.   

Abstract

1. In vivo clearance predictions from in vitro assays require scaling factors to relate the concentrations of hepatocytes or microsomal protein to the intact liver. 2. The aims were to measure the variability in scaling factors for Wistar rat and beagle dog for which the literature is particularly scarce and determine any sex differences. 3. Scaling factors were determined by comparing the cytochrome P450 (P450) content in hepatocytes or microsomes against the P450 content of fresh liver homogenate. The use of fresh homogenate is recommended as freezing can increase contamination and affect the P450 assay. 4. Mean(geo) hepatic microsomal concentrations in Wistar rats were 61 mg g(-1) liver (95% confidence interval (CI); 47-75 mg g(-1) liver) and in beagle dogs 55 mg g(-1) liver (95% CI = 48-62 mg g(-1) liver). Mean(geo) hepatocellularity was 163 x 10(6) cells g(-1) liver for Wistar rats (95% CI = 127-199 x 10(6) cells g(-1) liver) and 169 x 10(6) cells g(-1) liver (95% CI = 131-207 x 10(6) cells g(-1) liver) for beagle dogs. The data generated in this study indicate a consistency in scaling factors between rat and dog. No sex differences were observed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18988082     DOI: 10.1080/00498250802491662

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  18 in total

Review 1.  Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.

Authors:  Brandon Swift; Nathan D Pfeifer; Kim L R Brouwer
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

2.  Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics.

Authors:  Dominique A Ramirez; Keagan P Collins; Allister E Aradi; Katherine A Conger; Daniel L Gustafson
Journal:  Drug Metab Dispos       Date:  2018-12-19       Impact factor: 3.922

3.  Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation.

Authors:  Michael J Doerksen; Robert S Jones; Michael W H Coughtrie; Abby C Collier
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-12-19       Impact factor: 2.441

4.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

5.  Stereological assessment of sexual dimorphism in the rat liver reveals differences in hepatocytes and Kupffer cells but not hepatic stellate cells.

Authors:  Ricardo Marcos; Célia Lopes; Fernanda Malhão; Carla Correia-Gomes; Sónia Fonseca; Margarida Lima; Rolf Gebhardt; Eduardo Rocha
Journal:  J Anat       Date:  2016-02-19       Impact factor: 2.610

6.  Mass spectrometry-based quantification of CYP enzymes to establish in vitro/in vivo scaling factors for intestinal and hepatic metabolism in beagle dog.

Authors:  Aki T Heikkinen; Arno Friedlein; Jens Lamerz; Peter Jakob; Paul Cutler; Stephen Fowler; Tara Williamson; Roberto Tolando; Thierry Lave; Neil Parrott
Journal:  Pharm Res       Date:  2012-02-22       Impact factor: 4.200

7.  Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestine.

Authors:  Aki T Heikkinen; Arno Friedlein; Mariette Matondo; Oliver J D Hatley; Aleksanteri Petsalo; Risto Juvonen; Aleksandra Galetin; Amin Rostami-Hodjegan; Ruedi Aebersold; Jens Lamerz; Tom Dunkley; Paul Cutler; Neil Parrott
Journal:  Pharm Res       Date:  2014-07-18       Impact factor: 4.200

8.  Cloning/characterization of the canine organic anion transporting polypeptide 1b4 (Oatp1b4) and classification of the canine OATP/SLCO members.

Authors:  Chunshan Gui; Bruno Hagenbuch
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2010-01-14       Impact factor: 3.228

9.  Benzimidazole analogs as potent hypoxia inducible factor inhibitors: synthesis, biological evaluation, and profiling drug-like properties.

Authors:  Jianjun Chen; Jin Wang; Luciana P Schwab; Kyung-Tae Park; Tiffany N Seagroves; Lisa K Jennings; Duane D Miller; Wei Li
Journal:  Anticancer Res       Date:  2014-08       Impact factor: 2.480

10.  Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: application to development PBPK model in rats.

Authors:  Mihye Kwon; Jung Bae Park; Miwha Kwon; Jinho Song; Chang Su Yeo; Soo Hyeon Bae
Journal:  Arch Toxicol       Date:  2021-04-12       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.